Octagon Therapeutics
0 followers
‌
Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.
Industries
Headquarters
Employees
Links
Org chart
Isaac Stoner
President & CEO
Isaac Stoner
Collapse
Fred Ausubel
Founding CSO
Shen Yu
CTO
Brent Cezairliyan
VP of Biology
Nat Sherden
VP of Chemistry
Luis Castillo Menendez
Director of Translation & Development
